RK Pharma

Pearl River, NY

High Approval Rate 7+ Years Sponsoring

RK Pharma has sponsored 36 H1B visas since FY2019. The median H1B salary is $68,557.

H1B Visa Sponsorship Data • Updated with FY2025 data

Key Statistics

Total H1B Filings
36 Since FY2019
Median Salary
$68,557 FY2025
Approval Rate
100.0% FY2025
Years Active
7 FY2019-2025

H1B Salary Analysis at RK Pharma

Salary Range (FY2025)

$69K $63K 10th $80K 90th

Range shows where 80% of salaries fall. The marker indicates the median.

Based on 14 H1B filings.

Salary Frequency

$50K-$75K: 8 filings$75K-$100K: 6 filings$50K$75K2468

Hover over bars to see exact counts. Salary ranges in $25K increments.

Historical H1B Trends

Filings Over Time

2019 2021 2023 2025 1 8 15 H1B Filings

Median Salary Trend

2019 2021 2023 2025 $57k $93k $129k Median Salary

Approval Rate History

2019 2021 2023 2025 70% 80% 90% 100% Excellent Good Below Avg
Certified: 14 Denied: 0

Where & What RK Pharma Hires For

RK Pharma sponsors H1B workers at locations including Pearl River, NY for roles such as Chemists, Validation Engineers, Bioengineers and Biomedical Engineers.

Recent H1B Filings

View all 36 filings →

Year-by-Year Breakdown

Year Filings Median Salary Approval Rate
FY2025 14 $68,557 100.0%
FY2024 3 $63,086 100.0%
FY2023 8 $85,000 100.0%
FY2022 1 $117,000 100.0%
FY2021 4 $72,413 100.0%

Related H1B Sponsors

H1B Sponsors in New York

Frequently Asked Questions

Does RK Pharma sponsor H1B visas?
Yes, RK Pharma sponsors H1B visas. They have filed 36 H1B petitions since FY2019. In FY2025, they filed 14 H1B applications.
What is the H1B salary at RK Pharma?
The median H1B salary at RK Pharma is $68,557 as of FY2025. Salaries range from $63,086 (10th percentile) to $80,027 (90th percentile).
What is RK Pharma's H1B approval rate?
RK Pharma has a 100.0% H1B approval rate in FY2025, based on 14 filed petitions.
How many H1B visas does RK Pharma sponsor per year?
RK Pharma sponsors an average of 5 H1B visas per year. They have been sponsoring H1B workers for 7 years (FY2019-FY2025).